Tamsulosin for Benign Prostatic Hyperplasia
Tamsulosin (Flomax - Boehringer Ingelheim), an alpha 1 - adrenoreceptor blocker, has been approved by the FDA for treatment of benign prostatic hyperplasia (BPH). It is claimed to bind preferentially to alpha1 receptors in the prostate....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Tamsulosin for Benign Prostatic Hyperplasia
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1011
Article Code: 1011c
Date: October 10, 1997
Volume: 39
Page: 96
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1011
Article Code: 1011c
Date: October 10, 1997
Volume: 39
Page: 96
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)